MD Financial Management
GSK icon

MD Financial Management’s GSK GSK Stock Holding History

MD Financial Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$6K Hold
102
– – ﹤0.01% 302
2021
Q3 		$5K Hold
102
– – ﹤0.01% 293
2021
Q2 		$6K Hold
102
– – ﹤0.01% 294
2021
Q1 		$5K Hold
102
– – ﹤0.01% 226
2020
Q4 		$5K Buy
+102
New +$4.68K ﹤0.01% 107

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

MD Financial Management's GSK Position: Q4 2021 in Review

MD Financial Management held its GSK (GSK) position steady in Q4 2021 at 102 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

MD Financial Management first reported a position in GSK in Q4 2020 and has held it in 5 quarters since. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • MD Financial Management held 102 shares of GSK worth $6K as of Q4 2021.
  • MD Financial Management left its GSK share count unchanged in Q4 2021.
  • GSK made up ﹤0.01% of MD Financial Management's portfolio in Q4 2021, its #302 holding.
  • MD Financial Management first reported a position in GSK in Q4 2020 and has held it in 5 quarters since.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.